Navigation Links
Inverness Medical Innovations Announces Fourth Quarter 2007 Results
Date:2/20/2008

GAAP Adjustments Basis(a)

Net revenue $157,008 $- $157,008

Cost of sales 89,680 (3,906)(b)(c)(d) 85,774

Gross profit 67,328 3,906 71,234

Gross margin 43% 45%

Operating expenses:

Research and

development 13,917 (1,460)(c)(d) 12,457

Purchase of in-process

research and

development - - -

Selling, general and

administrative 44,584 (2,493)(c)(d) 42,091

Loss on dispositions,

net 307 (307)(e) -

Operating income 8,520 8,166 16,686

Interest and other income

(expense), net (650) 177(c) (473)

Income tax (benefit)

provision 1,843 552(i) 2,395

Net (loss) income $6,027 $7,791 $13,818

Net (loss) income per

common share:

Basic $0.15 $0.36

Diluted $0.15(l) $0.34(l)

Weighted average common

shares - basic 38,885 38,885

Weighted average common

shares - diluted 40,715(l) 40,715(l)

(a) In calculating net income or loss on an adjusted cash basis, the

Company excludes from net income or loss (i) certain non-cash

charges including amortization expense and stock-based compensation

expense, (ii) non-recurring charges and income, and (iii) certain

other charges and income that have a sign
'/>"/>

SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
2. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
3. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
4. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
7. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
8. Inverness - Chemogen Establish Exclusive License for TB Antibodies
9. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
10. B-Line Medical and Immersion Medical Announce Partnership
11. MIT researcher addresses biomedical engineering challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... IL (PRWEB) March 25, 2015 ... Symmetry® Top-Loading Balances and Analytical Balances to get ... expanded line of weighing balances from the trusted ... Toploading Balances increase your efficiency by providing ... variety of samples. Weighing modes include parts counting, ...
(Date:3/25/2015)... CORAL SPRINGS, Fla. , March 25, 2015 ... (HIT) strategy and management consulting firm, has launched ... reference publication to simplify tracking of ePrescribing regulatory ... "The ePrescribing regulatory landscape continues to ... offerings to deliver what the industry, and ultimately ...
(Date:3/25/2015)... HAGUE, Netherlands , March 25, 2015  EndoStim ... for chronic gastro-esophageal reflux disease (GERD) in the March ... Surgery . 2015; 157(3):556-567 ], establishing the long term ... The study included 25 patients with severe GERD ... prescribed daily proton pump inhibitor (PPI) medication for an ...
(Date:3/25/2015)... NEW YORK , March 25, 2015 ... has released today version 4 of Face2Gene, ... Novel Analysis from computers, as well as mobile devices. ... patterns of human malformations to present comprehensive and up-to-date ... the Annual Clinical Genetics Meeting, ACMG 2015, in ...
Breaking Biology Technology:New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Point-of-Care Partners Launches the ePrescribing State Law Capsule 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3FDNA Releases a Multi-Platform Version of Face2Gene, a Genetic Search and Reference Solution at ACMG 2015 2
... Ltd (ASX: PXS; Nasdaq: PXSL) announced today that ... fibrosis demonstrated excellent lung,function improvement following three months ... current marketed product rhDNase(1). The,improvement in lung function ... a previous study following two weeks of treatment., ...
... Therapeutics Corporation,today announced the appointment of Bruce A. ... member of its Board of Directors. Mr. Peacock ... LLC. Previously, he served,as the CEO or was ... several,successful entrepreneurial healthcare companies operating in therapeutic,diagnostic and ...
... 2008 In this report,entitled "MedPredict Thought ... experts discuss the key controversies,surrounding development of ... the,biopharmaceutical industry is underestimating the size of ... panel, there are a number of factors,stymieing ...
Cached Biology Technology:Cystic Fibrosis Trial In Children Returns Positive Data 2Cystic Fibrosis Trial In Children Returns Positive Data 3Cystic Fibrosis Trial In Children Returns Positive Data 4Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer 2New MedPredict Report Suggests Market for Alcoholism Therapies is Underestimated 2
(Date:3/17/2015)... March 17, 2015 Emotient, the leader ... today announced general availability of Emotient Analytics ... the analysis of facial expressions. The system analyzes ... content, products and services. It delivers audience response ... sentiment - as derived from facial evidence of ...
(Date:3/12/2015)... Va. , March 12, 2015 IriTech, ... and a member of the Texas Instruments Design Network, ... Naidu has demonstrated its IriShield USB MK2120U device ... scanning facility for pension distribution. The ... assembled to be marketed in India ...
(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March ... Registration here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost ... SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 Biometric ... to compete in several different markets and industries. ... currently witnessing an uptrend. Join ...
Breaking Biology News(10 mins):New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... Institute of Food Research, which is strategically funded ... proteins that destroy bacterial cells to combat potentially ... specifically target certain bacteria, and IFR has been ... a common and dangerous source of hospital-acquired infections. ...
... to the puzzle of scaling how patterns stay in ... develops. In a new study appearing in Current Biology, Institute ... Danny Ben-Zvi of the Molecular Genetics Department have shown how ... the vein structure stays perfectly proportioned and their findings ...
... Male adult helminthomorph millipedes usually have one or ... into sexual appendages. These specialized gonopods are used as ... transfer sperm. New research published in BioMed Central,s open ... in detail at millipede development and the internal reorganization ...
Cached Biology News:Tuning natural antimicrobials to improve their effectiveness at battling superbugs 2Scale models 2The secret life of millipedes 2
... mixture excluding l-[U-14C]methionine, 1.85 MBq, 50 ... sterilized. > 1.85 GBq/mg atom ... Mixture of Ala, Arg, Asp, ... Phe, Pro, Ser, Thr, Tyr and ...
The Spheroplast Kit contains qualified reagents for the preparation of yeast spheroplasts. The reagents have been optimized for use with Pichia pastoris and are guaranteed to generate 70% spheroplast...
...
...
Biology Products: